Simon Lund has joined HarbourVest Partners as head of sales and marketing for Europe and MENA. He previously was with SVG Advisors.
2 min read · 20 April 2010
AMSTERDAM (Reuters) - CVC Capital Partners and a consortium of Morgan Stanley (MS.N) Infrastructure, 3i Infrastructure (3IN.L) and Star Capital have made indicative offers in the 2 billion pound ($3.1 billion) auction of HSBC's (HSBA.L) rolling stock firm, several people familiar with the matter said. HSBC's (0005.HK) rail unit Evershot has a UK fleet of over 4,000 trains and its sale follows the rationale of the divestments of the other two UK train leasing companies, as banks look to raise cash by disposing assets not central to their businesses.
1 min read · 20 April 2010
1 min read · 20 April 2010
Oak Hill Capital Partners has agreed to acquire ViaWest Inc., a provider of mission-critical technology infrastructure services, from Trinity Equity Investors, Goldman Sachs and Quilvest. No financial terms were disclosed.
4 min read · 20 April 2010
Lone Star Funds has completed its take-private acquisition of hotel owner and operator Lodgian Inc. (NYSE: LGN) for approximately $270 million (including assumed debt). Lodgian stockholders received $2.50 per share.
2 min read · 20 April 2010
Stone Point Capital and Hellman & Friedman have agreed to acquire Sedgwick Claims Management Services Inc., a Temphis, Tenn.-based provider of claims and productivity management solutions to corporate and institutional clients. The deal is valued at $1.1 billion, with sellers including Fidelity National Financial, THL Partners and Evercore Capital Partners.
3 min read · 20 April 2010
OMERS Private Equity has agreed to acquire U.S. Infrastructure Corp. from Kohlberg & Co. No financial terms were disclosed. USIC is an Indianapolis-based provider of outsourced sub-surface utility locating services, and was formed in 2008 via the merger of SM&P and CLS.
2 min read · 20 April 2010
Mohammad Almojel has joined Atlantic-Pacific Capital as a principal in the firm's private funds business, with a focus on the Middle East. He previously was an associate director with MerchantBridge Private Equity in Dubai.
2 min read · 20 April 2010
Paul Capital Healthcare has acquired from Dyax Corp. (Nasdaq: DYAX) the rights to royalties and other payments related to the commercialization of Xyntha by Pfizer Inc. The deal is valued at $12 million, including a $10 million up-front payment. Xynthia is a recombinant factor VIII product for patients with hemophilia A.
5 min read · 20 April 2010
1 min read · 20 April 2010